Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,969 recalls, newest first

Class I · High risk

Xiyouji Qingzhi Capsule

Marketed without an Approved NDA/ANDA: Products found to contain undeclared sibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.

Terminated Chemical / undeclared Dolphin Intertrade Corporation D-1250-2014
Class I · High risk

JaDera

Marketed without an Approved NDA/ANDA: Products found to contain undeclared sibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.

Terminated Chemical / undeclared Dolphin Intertrade Corporation D-1249-2014
Class II · Moderate risk

Enablex (darifenacin)

Failed Impurities/Degradation Specifications: unspecified degradation product

Terminated Impurity / degradation Warner Chilcott US LLC NDC 0078-9420-07 D-822-2013
Class II · Moderate risk

Ranitidine Syrup

Failed Impurity/Degradation Specification; "Related Compound C"

Terminated Impurity / degradation Actavis South Atlantic LLC D-829-2013
Class III · Low risk

Excedrin

Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing

Terminated Impurity / degradation Novartis Consumer Health NDC 0067-2062-02 D-744-2014
Class III · Low risk

Theraflu Warming Relief

Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing

Terminated Impurity / degradation Novartis Consumer Health NDC 0067-6438-08 D-742-2014
Class III · Low risk

Maximum Strength Comtrex

Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing.

Terminated Impurity / degradation Novartis Consumer Health NDC 0067-2081-24 D-741-2014
Class III · Low risk

Maximum Strength Comtrex

Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing.

Terminated Impurity / degradation Novartis Consumer Health NDC 0067-2084-24 D-740-2014
Class II · Moderate risk

Proplete 45 - 51 KG

Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions.

Terminated Sterility / contamination Pentec Health D-592-2013
Class II · Moderate risk

Proplete 90+ KG

Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions.

Terminated Sterility / contamination Pentec Health D-591-2013
Class II · Moderate risk

Proplete 80+ KG

Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions.

Terminated Sterility / contamination Pentec Health D-590-2013
Class II · Moderate risk

Proplete 70+ KG

Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions

Terminated Sterility / contamination Pentec Health D-589-2013
Class II · Moderate risk

Proplete 60 - 69 KG

Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions.

Terminated Sterility / contamination Pentec Health D-588-2013
Class II · Moderate risk

Proplete 52 - 59 KG

Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions.

Terminated Sterility / contamination Pentec Health D-587-2013
Class II · Moderate risk

Proplete 40 - 44 KG

Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions.

Terminated Sterility / contamination Pentec Health D-586-2013
Class II · Moderate risk

Idpn

Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions.

Terminated Sterility / contamination Pentec Health D-585-2013

Recalls by year